14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
PRE vs CNA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CNA Overall Winner
6-Pillar Tally: PRE 1 – 5 CNA
Matrix Metrics: PRE 1 – 9 CNA
As of Nov 16, 2026, CNA Financial Corporation (CNA) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRE carries a Unified Composite Score of 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin), whereas CNA carries 55.0/100 (HOLD) at $48.50 (10.5x Forward P/E, 9.4% operating margin).
Growth vs. Quality Trade-Off: CNA earns the overall head-to-head edge with a stronger Unified Composite Score (55.0/100 HOLD vs. PRE 49.8/100 HOLD) and -0.14β · 19% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: PRE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1); meanwhile CNA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 55.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRE vs CNA. Trailing 12-month operating profitability (PRE -34.6% vs CNA 9.4%) and valuation multiples (PRE N/M vs CNA 10.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Property & Casualty value chain with $13.1B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment19.6% of Rev ($2.97B)
90D Engineering Disclosures0 Published
Investor FAQ PRE vs CNA Key Questions & Quantitative Answers
As of Nov 16, 2026, CNA Financial Corporation (CNA) is the stronger overall head-to-head candidate over Prenetics Global Limited Class A Ordinary Share (PRE) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PRE carries a Unified Composite Score of 49.8/100 (HOLD) at $15.48 (N/M Forward P/E, -34.6% operating margin), whereas CNA carries 55.0/100 (HOLD) at $48.50 (10.5x Forward P/E, 9.4% operating margin). Growth vs. Quality Trade-Off: CNA earns the overall head-to-head edge with a stronger Unified Composite Score (55.0/100 HOLD vs. PRE 49.8/100 HOLD) and -0.14β · 19% Vol risk profile, whereas PRE leads top-line expansion (+210.7% YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PRE is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.1); meanwhile CNA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 55.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PRE leads the Growth & Scale pillar: PRE posts +210.7% YoY revenue growth and +0.0% YoY earnings growth on $155M TTM revenue (57.8% gross margin, -34.6% operating margin), compared with CNA at +0.1% YoY revenue growth and -51.4% YoY earnings growth on $15.2B TTM revenue (29.0% gross margin, 9.4% operating margin). On trailing 12-month operating scale, PRE generates $155M in USD-normalized revenue versus $15.2B for CNA. In operating R&D and SG&A reinvestment, PRE deploys N/A (0 90-day corporate R&D disclosures) versus 19.6% of Rev ($2.97B) (0 disclosures) for CNA.
CNA screens cheaper on headline valuation multiples. PRE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.7x EV/Revenue (-34.9% EBITDA margin), whereas CNA trades at 10.5x Forward P/E, 12.8x Trailing P/E, 0.92x PEG, and 0.9x EV/Revenue (9.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PRE (-47.0% ROE) versus CNA (9.6% ROE) capital efficiency.
In options market volatility and institutional positioning, PRE carries 124.1% implied volatility (18th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.63β · 74% Vol realized risk). By comparison, CNA carries 13.0% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.14β · 19% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.